Doxazosin mesylate
- Product NDC
- 71610-251
- 11-digit product format
- 716100251
- Labeler code
- 71610
- Product ID
- 71610-251_f64dd0e4-d9bf-465c-9e36-2a6ce89651f7
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Application
- NDA019668
- Marketing category
- NDA
- Marketing start
- 2014-07-07
- Marketing end
- 0000-00-00
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71610-251 | DOXAZOSIN MESYLATE TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | Legacy NDC | 20190405_07638460-46c5-4fa1-a581-9a11fd8ed7bd.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 71610-251-60 | 71610025160 | 90 TABLET in 1 BOTTLE (71610-251-60) | 90 tablet | 2019-03-18 | 0000-00-00 | No | No | Current |